CTRI/2017/08/009329已完成未知
Efficacy and safety of sodium benzoate in the management of hyperammonemia in infants, children and adoloscents with Chronic liver disese - Randomised Controlled Trial
Department of Pediatric Hepatology0 个研究点目标入组 108 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 108
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Infants, children and adolescents under 18 years of age with decompensated Chronic liver disease with hyperammonemia < 400 mcgm and /dl.
排除标准
- •1. Patients who have received sodium benzoate within 1 week prior to evaluation.
- •2. Baseline serum sodium above 155 mEq/L
- •3. Patients with Grade 3 ascites as per IAC classification.
- •4. Patients who did not give a written informed consent.
研究者
相似试验
已完成
4 期
The Efficacy of Sodium Benzoate as an Adjunctive Treatment in Early PsychosisEarly psychosis (including schizophrenia, schizophreniform psychosis, delusional disorder, bipolar disorder, psychosis not otherwise specified)Mental Health - SchizophreniaMental Health - Psychosis and personality disordersACTRN12615000187549The University of Queensland100
进行中（未招募）
不适用
Sodium benzoate for treatment of attenuated psychosisEUCTR2013-000458-23-FIiuvannniemi Hospital140
已完成
不适用
Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease.Chronic Liver DiseaseNCT04022941Institute of Liver and Biliary Sciences, India108
招募中
2 期
Dose finding clinical trial of sodium benzoate in people with treatment refractory schizophreniaTreatment refractory schizophreniaMental Health - SchizophreniaSchizophreniaACTRN12621000327886QIMR Berghofer Medical Institute of Research52
已完成
2 期
Phase II Study of Sodium Phenylbutyrate, Sodium Benzoate, Sodium Phenylacetate, and Dietary Intervention for Urea Cycle DisordersAmino Acid Metabolism, Inborn ErrorsNCT00004767National Center for Research Resources (NCRR)20